US Patent Issued to MALLINCKRODT PHARMACEUTICALS IRELAND on April 29 for "Methods to improve organ viability" (Missouri Inventor)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,285,008, issued on April 29, was assigned to MALLINCKRODT PHARMACEUTICALS IRELAND Ltd. (Dublin).

"Methods to improve organ viability" was invented by Jim Potenziano (Hazelwood, Mo.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods to improve the viability of an organ, or organs, by continuously administering a composition comprising NOx gas directly to the organ(s)."

The patent was filed on Jan. 10, 2024, under Application No. 18/409,181.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool...